1,071 women under 40, and three different places the clock ran slow
What happened
A new study published today has put numbers on something many younger women with breast cancer have described for years: the wait. The research appeared on 12 October 2026 in CANCER, a peer-reviewed journal published by the American Cancer Society. The senior author is Dr Kristen Brantley of the Dana-Farber Cancer Institute in Boston. The team used data from the Young Women's Breast Cancer Study. This is a long-running project that follows women who were diagnosed with breast cancer at or before the age of 40. The researchers looked at 1,071 of those women and measured how long things took at three separate points in their care. They set a clear definition for each delay. A 'presentation delay' meant 90 days or more between a woman first noticing a symptom and seeing a clinician about it. This happened in 153 cases. A 'diagnostic delay' meant 90 days or more between that first appointment and the biopsy that confirmed cancer. This happened in 120 cases. A 'treatment delay' meant 60 days or more between diagnosis and the start of treatment. This happened in 228 cases. So in a group of just over a thousand women, hundreds hit at least one of those marks. Dr Brantley said the study "reveals continued issues in care delay among patients with young-onset breast cancer". She added that both patients and clinicians need a better understanding of the risk factors and symptoms of breast cancer in younger women.
Why this matters
Breast screening programmes are built around older women, and for good reason: that is where most breast cancer is found. In the UK, the NHS Breast Screening Programme invites women from the age of 50. That means almost every woman diagnosed under 40 gets there a different way. She notices something herself, or someone notices it for her. There is no routine scan waiting to catch it. That puts a lot of weight on two things. The first is whether a young woman takes a change in her breast seriously. The second is whether the person she tells takes it seriously too. This study suggests both links in that chain can stretch. There is a second finding that matters just as much. Lower annual income was linked to higher odds of a presentation delay. In other words, women with less money were more likely to wait a long time before going to a clinician at all. Money should not decide how quickly a lump gets looked at, but the data says it plays a part. The study also found that younger age was linked to higher odds of a diagnostic delay. The younger the patient, the longer the gap between her first appointment and her biopsy tended to be. That is a difficult thing to read, because youth is exactly the reason cancer is often not the first thing anyone suspects.
What the evidence actually says
It is worth being precise here, because this is an area where headlines often run ahead of the research. The study found that delays were linked to later-stage disease. Women with diagnostic delays were more likely to have cancer that had already advanced. Presentation delay was linked to later-stage disease in women with certain HER2-positive tumours. But the researchers did not find a link between these delays and survival. In this group of women, delays were not associated with how long patients lived, or with how long they stayed cancer-free. That is an important and slightly surprising result, and the authors do not brush past it. They point out that a later-stage diagnosis often means more extensive treatment: bigger surgery, radiotherapy, or more drug treatment. That has a real cost in quality of life, even when it does not change survival. So the honest summary is this. Waiting was common. Waiting was linked to more advanced disease and heavier treatment. Waiting was not shown, in this study, to cost lives. Some other findings cut against what you might expect. Women who were pregnant at diagnosis, women with a family history of breast cancer, and women with triple-negative tumours were all less likely to have a presentation delay. Patients with more aggressive tumour types were less likely to have treatment delays. Fast-moving or clearly worrying cases tended to move faster through the system, which is reassuring in its own way. One caveat. This is a study of women in the United States, where health insurance shapes access in ways it does not in the UK. The pattern it describes, though, is one that UK charities and clinicians have raised repeatedly.
Practical advice
If you are under 40, you will not get a screening invitation. That does not mean there is nothing to do. Get to know what is normal for you. Breasts change through the month, through pregnancy and through life. The point is not to hunt for lumps on a schedule. It is to be familiar enough with your own body that a change stands out. The NHS advises seeing a GP if you notice a lump or swelling in the breast, upper chest or armpit; a change in skin texture such as puckering or dimpling; a change in the size or shape of a breast; a rash or crusting around the nipple; nipple discharge; a nipple that has become inverted; or ongoing pain in the breast or armpit. If you do go, say plainly what you have noticed and how long it has been there. Dates help. 'I found this six weeks ago and it has not gone away' is more useful than 'it has been a while'. If you are not satisfied with the answer, go back. This study found that the gap between a first appointment and a diagnosis can be long. Returning is not being a nuisance; it is giving the system a second chance to get it right. Most breast changes are not cancer. That is the usual outcome, and it is worth holding on to. But the only way to know is to have it looked at.
What to know
A study of 1,071 women diagnosed with breast cancer at or before 40 found delays were common at three points: 153 waited 90 days or more before seeing a clinician, 120 waited 90 days or more from that appointment to diagnosis, and 228 waited 60 days or more from diagnosis to treatment. Lower income was linked to longer presentation delays, and younger age to longer diagnostic delays. Delays were linked to later-stage disease, though not to survival in this group. If you are under 40, you are below the NHS screening age, so knowing your own body and acting on changes is the practical safeguard. Go to your GP with a clear account of what has changed and when. Go back if nothing improves. Sources: Wiley / CANCER (American Cancer Society), "Are young women receiving delayed care for breast cancer?", 12 October 2026, https://www.eurekalert.org/news-releases/1146739 ; Brantley et al., "Delays in breast cancer presentation, diagnosis, and treatment in young women", CANCER, 12 October 2026, DOI 10.1002/cncr.70594, https://doi.org/10.1002/cncr.70594 ; NHS, "Breast cancer in women - Symptoms", https://www.nhs.uk/conditions/breast-cancer/symptoms/ ; NHS, "Breast screening (mammogram)", https://www.nhs.uk/conditions/breast-screening-mammogram/ This article is for general information and does not replace advice from a doctor, pharmacist or other qualified healthcare professional. If you have noticed a change in your breast, contact your GP.
Related articles
Six hours, not never: the ICU filter notice the MHRA issued today
The UK's medicines and devices regulator has issued a new safety notice to hospitals, and it is about timing. On 13 October 2026 the Medicines and Healthcare p…
Eight pages to a minister: what the data guardian says trust is worth
On 12 October 2026, the government published a letter about who should be trusted with NHS patient data. It was written by Dr Nicola Byrne, the National Data G…
Update: the tests came back, and it was not plague
This is a follow-up to a story we covered on 5 October, when nearly 200 people were being monitored after the death of a laboratory worker in Siberia. There has…